2291 studies were found. Here are studies 1 to 50.

1.		Recruiting	12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
2.		Recruiting	131MIBG to Treat Malignant Pheochromocytoma Condition: Pheochromocytoma
3.		Recruiting	17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer
4.		Recruiting	17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors Condition: Cancer
5.		Recruiting	17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas Conditions: adult solid tumor; Leukemia; Lymphoma
6.		Recruiting	17-DMAG to Treat Patients with Solid Tumors or Lymphomas Conditions: Neoplasms; Lymphoma
7.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma Condition: Cancer
8.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
9.		Not yet recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
10.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...
11.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome
12.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma
13.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ...
14.		Recruiting	17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease Conditions: Hippel-Lindau Disease; Kidney Cancer
15.		Recruiting	2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific
16.		Not yet recruiting	3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
17.		Recruiting	3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
18.		Recruiting	3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer Conditions: unresectable extrahepatic bile duct cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; recurrent extrahepatic bile duct cancer; ...
19.		Recruiting	3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia
20.		Recruiting	3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
21.		Recruiting	3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ...
22.		Recruiting	3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
23.		Recruiting	3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction Conditions: recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus
24.		Recruiting	4-PBA: Will it increase the level of Alpha 1-Antitrypsin(AAT) in persons with AAT deficiency? Condition: alpha 1-Antitrypsin Deficiency
25.		Recruiting	506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma
26.		Recruiting	ABT-751 in Treating Young Patients With Refractory Solid Tumors Condition: childhood cancer
27.		Recruiting	ABX-EGF in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Chemotherapy Conditions: adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
28.		Recruiting	ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer Conditions: Colorectal Cancer; Metastases
29.		Recruiting	ACP-103 to Treat Parkinson's Disease
30.		Recruiting	Activation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
31.		Recruiting	Active Crohn’s Disease Study Condition: Crohn Disease
32.		Recruiting	Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA Condition: Renal Cell Carcinoma
33.		Recruiting	Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma Conditions: epithelial mesothelioma; localized malignant mesothelioma; advanced malignant mesothelioma
34.		Recruiting	Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms Condition: Interstitial Cystitis
35.		Not yet recruiting	Acupuncture for Women's Health Conditions Conditions: Ovarian Neoplasms; Endometriosis; Pelvic Pain; Uterine Neoplasms
36.		Recruiting	Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Conditions: Cancer; oral complications of cancer and cancer therapy; Pain
37.		Recruiting	Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer Condition: Colorectal Neoplasms
38.		Recruiting	Acute Myeloid Leukemia Study Condition: Acute Myeloid Leukemia
39.		Recruiting	Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Conditions: Acute Respiratory Distress Syndrome; Lung Diseases
40.		Recruiting	Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease Condition: Crohn's Disease
41.		Recruiting	Adjunct CellCept (mycophenolate mofetil) with Reduced Corticosteroids in Subjects with Myasthenia Gravis Condition: Myasthenia Gravis
42.		Recruiting	Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma Conditions: stage II multiple myeloma; stage III multiple myeloma
43.		Recruiting	Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
44.		Recruiting	Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
45.		Not yet recruiting	Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
46.		Recruiting	Adjuvant Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer Conditions: bone metastases; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
47.		Recruiting	Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Condition: Head and Neck Cancer
48.		Recruiting	Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer Conditions: Colon Cancer; liver metastases; Rectal Cancer
49.		Recruiting	Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
50.		Recruiting	Adjuvant Oxaliplatin and Capecitabine Compared With Fluorouracil and Leucovorin in Treating Chemotherapy-Naïve (Not Previously Treated) Patients Who Have Undergone Resection for Stage III Colon Cancer Condition: stage III colon cancer